# FDA recall D-0660-2020

> **Sun Pharmaceutical Industries, Inc.** · Class II · drug recall initiated 2019-12-26.

## Product

Sumatriptan Succinate Tablets, 100 mg  packaged in 9 (1X9) Unit-of-use blister card, (62756-0522-69), Rx only, Sun Pharma, Cranbury, NJ

## Reason for recall

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

## Distribution

Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.

## Key facts

- **Recall number:** D-0660-2020
- **Recalling firm:** Sun Pharmaceutical Industries, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-12-26
- **Report date:** 2020-01-22
- **Termination date:** 2020-10-22

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Cranbury, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0660-2020

## Citation

> AI Analytics. FDA recall D-0660-2020. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0660-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*